Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis
Yanqing Liu et al.
CELL DEATH & DISEASE (2022)
The Role of Cancer-Associated Fibroblasts in Ovarian Cancer
Mo Zhang et al.
CANCERS (2022)
Role of NRF2 in Ovarian Cancer
Giovanni Tossetta et al.
ANTIOXIDANTS (2022)
NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
Rongrong Wu et al.
CANCERS (2022)
Targeting the tumour microenvironment in platinum-resistant ovarian cancer
M. Cummings et al.
SEMINARS IN CANCER BIOLOGY (2021)
Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation
Marjolijn M. Ladan et al.
CANCERS (2021)
Platinum Complexes in Colorectal Cancer and Other Solid Tumors
Beate Koeberle et al.
CANCERS (2021)
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
Lajos Pusztai et al.
CANCER CELL (2021)
Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63
Yingjie Liu et al.
NATURE COMMUNICATIONS (2021)
Applications of Aptamers in the Diagnosis and Treatment of Ovarian Cancer: Progress From 2016 to 2020
Luoshan Ruan et al.
FRONTIERS IN GENETICS (2021)
The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma
Hongpan Zhang et al.
FRONTIERS IN GENETICS (2021)
Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy
Aya Saleh et al.
CANCERS (2021)
Deciphering the Collagen code in tumor progression
Archana Anshuman Gupta et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2021)
Targeting TGFβ signal transduction for cancer therapy
Sijia Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway
Elena Marinelli Busilacchi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Zeda Zhang et al.
CANCER CELL (2020)
Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Alvaro Quintanal-Villalonga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Xueke Shi et al.
BIOMOLECULES (2020)
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin
Roberto Campagna et al.
ANTIOXIDANTS (2020)
TISIDB: an integrated repository portal for tumor-immune system interactions
Beibei Ru et al.
BIOINFORMATICS (2019)
The International Cancer Genome Consortium Data Portal
Junjun Zhang et al.
NATURE BIOTECHNOLOGY (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway
Xiao-lei Gao et al.
BMC CANCER (2019)
ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer
Zhuqing Li et al.
CLINICAL CANCER RESEARCH (2019)
Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer
Wei Sun et al.
ONCOLOGY LETTERS (2019)
The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
Nele Loret et al.
CANCERS (2019)
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
Renata A. Tassi et al.
BRITISH JOURNAL OF CANCER (2019)
Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma
Yuanliang Yan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
Update of the FANTOM web resource: expansion to provide additional transcriptome atlases
Marina Lizio et al.
NUCLEIC ACIDS RESEARCH (2019)
Epigenetic therapy for ovarian cancer: promise and progress
Sara Moufarrij et al.
CLINICAL EPIGENETICS (2019)
Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment
Belinda van Zyl et al.
ENDOCRINE-RELATED CANCER (2018)
LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
Hai Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling
Cassandra Ringuette Goulet et al.
MOLECULAR CANCER RESEARCH (2018)
TGF--mediated LEFTY/Akt/GSK-3/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas
Toshihide Matsumoto et al.
MOLECULAR CARCINOGENESIS (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
Galaxia M. Rodriguez et al.
CANCERS (2018)
Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer
Xin Wu et al.
CELL DEATH & DISEASE (2018)
Downregulation of TGF-1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling
Yanqiu Wang et al.
BIOLOGICAL RESEARCH (2018)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-β1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers
Taylan Turan et al.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
ARID1A gene mutation in ovarian and endometrial cancers
Takashi Takeda et al.
ONCOLOGY REPORTS (2016)
The hallmarks of CAFs in cancer invasion
Youmna Attieh et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2016)
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells
Noemi Arrighetti et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
The Genotype-Tissue Expression (GTEx) Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
The Genotype-Tissue Expression (GTEx) Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
The role of the orphan nuclear receptor COUP-TFII in tumorigenesis
Mafei Xu et al.
ACTA PHARMACOLOGICA SINICA (2015)
Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer
Q. H. Miow et al.
ONCOGENE (2015)
Identification of the IGF1/PI3K/NFκB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
Madhuri Koti et al.
BMC CANCER (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Multiple roles of COUP-TFII in cancer initiation and progression
Lacey M. Litchfield et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Expression of TGFβ1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin
Shinichi Komiyama et al.
ONCOLOGY REPORTS (2011)
Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model
Amy L. Creekmore et al.
PLOS ONE (2011)
Transforming growth factor-β1, transforming growth factor-β2, and transforming growth factor-β3 enhance ovarian cancer metastatic potential by inducing a smad3-dependent epithelial-to-mesenchymal transition
Thuy-Vy Do et al.
MOLECULAR CANCER RESEARCH (2008)
COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells
Francois Le Dily et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Profiling molecular targets of TGF-beta 1 in prostate fibroblast-to-myofibroblast transdifferentiation
G Untergasser et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2005)
Share Paper
